SeqOne at ESHG 2023: A.I. for Diagnostics
We will be hosting a corporate satellite on Monday, June 12, 2023 – 14.00 – 15.30 BST : “Harnessing AI to improve diagnostic yield with large-scale NGS data“
Location: room Alsh 1, level 0.
During our seminar you will learn how our latest advances in Artificial Intelligence and genomics enable us to revolutionize the way you diagnose rare diseases. Our speakers will cover a range of topics, including exome sequencing, phenotyping, machine learning, and clinical validation.
Speakers:
- Laurent Mesnard, Head of Nephrology, AP-HP Hospitals
- Julien Thevenon, Professor of Genomics, Grenoble Hospital / interpretation coordinator of the French National Genomics program’s AURAGEN lab
- Kevin Yauy, MD, Precision medicine & AI specialist, Clinician, Montpellier Hospital
- Geoffroy Delplancq, Medical Geneticist, Versailles Hospital
- Michaël Blum, Head of R&D, SeqOne Genomics
Coming soon: white paper “The Use of A.I. for Advanced Variant Prioritization”
We will release soon a new white paper about the use of A.I. for advanced variant prioritization.
Fill out the form below to receive it when available.
SeqOne’s program
Sunday, June 11th, 13:00-14:00 BST
- Poster presentation 1: Clinical evaluation of a low-coverage whole-genome test for homologous recombination deficiency detection in ovarian cancer. Speaker: Céline Gottin
- Poster presentation 2: Towards implementing Nanopore sequencing for routine molecular diagnosis of germline cancer predisposition. Speaker: Marie Mille
Monday, June 12th, 13:00-14:00 BST
- Poster presentation 1: LoRID: a bioinformatic pipeline to discover alternative isoforms using nanopore long-read sequencing. Speaker: Nicolas Soirat
- Poster presentation 2: SeqOne rank+, a machine learning model to rank genetic variants based on phenotypes and ACMG standards criteria. Speaker: Jiri Ruzicka
- Poster presentation 3: DrugOrder: an automated method for ranking variant/drug associations using large panel of cancer genes. Speaker: Michaël Blum
Monday, June 12th, 14:00-15:30 BST
Corporate satellite: Harnessing AI to improve diagnostic yield with large-scale NGS data
Location: Room Alsh 1, level 0
Speakers:
- Laurent Mesnard, Head of Nephrology, AP-HP Hospitals
- Julien Thevenon, Professor of Genomics, Grenoble Hospital / interpretation coordinator of the French National Genomics program’s AURAGEN lab
- Kevin Yauy, MD, Precision medicine & AI specialist, Clinician, Montpellier Hospital
- Geoffroy Delplancq, Medical Geneticist, Versailles Hospital
- Michaël Blum, Head of R&D, SeqOne Genomics
ESHG program
Learn about the full ESHG program: https://2023.eshg.org/programme-at-a-glance/
Similar readings
-
News Press release22 February 2023
SeqOne’s new clinically validated HRD test reduces the number of inconclusive results to improve the prescription of targeted treatments for ovarian cancer patients
The Homologous Recombination Deficiency (HRD) biomarker identifies ovarian cancer patients likely to respond to PARP inhibitors. SeqOne’s test simplifies the deployment of this test while [...]
-
News Platform features Press release Science
9 February 2023
SeqOne Genomics and the French Thrombotic MicroAngiopathies National reference center (CNR-MAT) pioneer the use of Oxford Nanopore sequencing technology to improve patient outcomes in kidney disease while reducing turnaround times
Montpellier, February 9th, 2023: SeqOne today announced the results of a long-standing research collaboration with Pr. Laurent Mesnard, Co-Director of the French National center for Thrombotic MicroAngiopathies (CNR-MAT), aimed at improving [...]
-
News Press release
21 October 2022
Michael Blum joins SeqOne Genomics to head the company’s Research and Development
Renowned specialist in healthcare data science, he will focus on developing A.I. driven genomic analysis solutions to facilitate personalised medicine in oncology and rare diseases [...]
